Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice-Reference-Cited by-同舟云学术

Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice

Published:2015-12-29 Issue:12 Volume:10 Page:e0144660
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Boosalis Michael S.,Sangerman Jose I.,White Gary L.,Wolf Roman F.,Shen Ling,Dai Yan,White Emily,Makala Levi H.,Li Biaoru,Pace Betty S.,Nouraie Mehdi,Faller Douglas V.,Perrine Susan P.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference50 articles.

1. The inherited diseases of hemoglobin are an emerging global health burden;DJ Weatherall,2010

2. Changes in the epidemiology of thalassemia in North America: a new minority disease;EP Vichinsky,2005

3. Pharmacologic modulation of fetal hemoglobin;MH Steinberg;Medicine,2001

4. Transcriptional regulation of fetal to adulthemoglobin switching: new therapeutic opportunities;A Wilbur,2011

5. Reawakening fetal hemoglobin: prospects for new therapies for the beta- globin disorders;DE Bauer,2012

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of small molecule agonists of fetal hemoglobin expression for the treatment of sickle cell disease;2024-07-03

2. Pharmacogenomics of Drugs Used in β-Thalassemia and Sickle-Cell Disease: From Basic Research to Clinical Applications;International Journal of Molecular Sciences;2024-04-12

3. The state of the art of fetal hemoglobin-inducing agents;Expert Opinion on Drug Discovery;2022-11-02

4. A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs;Wellcome Open Research;2022-08-17

5. A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established Drugs;Wellcome Open Research;2022-06-23